Document Detail


Marine n-3 Fatty Acids for Cardiovascular Risk Reduction and Disease Control in Rheumatoid Arthritis: "Kill Two Birds with One Stone"?
MedLine Citation:
PMID:  22364137     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Rheumatoid arthritis (RA), the most common chronic systemic inflammatory disease leading to joint destruction and disability, is associated with increased cardiovascular mortality. Systemic inflammation and increased burden of traditional cardiovascular risk factors present in RA are currently considered responsible for the accelerated atherosclerosis in these patients. Herein, we highlight a potential double effect of dietary intake of the n-3 long-chain polyunsaturated fatty acids (LCP) eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) on cardiovascular risk reduction and disease control in patients with RA. Large studies in non-RA populations provide strong evidence for the beneficial effect of n-3 LCP supplementation in primary and secondary cardiovascular prevention. Cardiovascular risk reduction is at least partly explained by n-3 LCP effects on blood pressure, dyslipidemia, thrombosis and inflammation, all important factors also in RA, whereas abnormalities in vascular function and in vascular morphology similar to those observed in RA patients may even be moderately reversed. On the other hand, there is evidence from 6 of 14 randomized controlled trials supporting a favorable effect of n-3 LCP supplementation in decreasing joint inflammation in RA. Although specific studies in RA patients are currently lacking, a double beneficial effect of n-3 LCP seems likely. The size of any such effect and how it compares with other interventions such as lifestyle changes, biologic therapies, and statin therapy, needs to be investigated prospectively in carefully designed studies.
Authors:
Victoria G Rontoyanni; Petros P Sfikakis; George D Kitas; Athanase D Protogerou
Related Documents :
12697177 - The fate of chlorine and organic materials in swimming pools.
11010937 - Postprandial modulation of dietary and whole-body nitrogen utilization by carbohydrates...
3048267 - Participation of histidine in biosynthesis of the pyrimidine moiety of thiamin in sacch...
15941887 - Dietary peptides increase endogenous amino acid losses from the gut in adults.
16204227 - Glycosylphosphatidylinositol-anchored fungal polysaccharide in aspergillus fumigatus.
19537157 - Temperature influences synonymous codon and amino acid usage biases in the phages infec...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-24
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, "Laikon" Hospital, Ag. Thoma, 17, 11527 Athens, Greece. vic.rontoyanni@gmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the rece...
Next Document:  Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Resear...